Microbio is pleased to announce its two COVID-19 tests have been approved for sale in Europe under the IVD Directive 98/79/EC.
Microbio Pty Ltd, an Australian-owned biotech company has been awarded a Federal Government Accelerating Commercialisation Grant to commercialise Microbio’s InfectID-Blood Stream Infection (BSI) diagnostic assay. Read more in the full media release.
Microbio has developed a new type of COVID-19 test that has the potential to determine not only if someone has the virus but also if they are infectious.
Microbio today announced its ground-breaking InfectID-COVID-19-R test which has been independently validated to identify the presence of replication-competent SARS-CoV-2 virus in samples in 45 minutes (post RNA extraction).